Other
Sales in Other rose by €1,306 million compared with 2020 to €3,666 million. This was primarily the result of higher sales in commodity trading.
At –€643 million, income from operations before special items in Other was €126 million above the prior-year figure. This was largely attributable to lower miscellaneous income and expenses, as well as a higher contribution from other businesses.
EBIT rose by €562 million to –€641 million. This included special income, mainly from the partial release of provisions for the restructuring of the Global Business Services unit. In the previous year, special charges arose for their recognition.
|
2021 |
2020 |
+/– |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales |
3,666 |
2,360 |
55.3% |
|||||||||||||
Income from operations before depreciation, amortization and special items |
–489 |
–609 |
19.7% |
|||||||||||||
Income from operations before depreciation and amortization (EBITDA) |
–484 |
–1,032 |
53.1% |
|||||||||||||
Depreciation and amortizationb |
157 |
171 |
–8.2% |
|||||||||||||
Income from operations (EBIT) |
–641 |
–1,203 |
46.8% |
|||||||||||||
Special items |
3 |
–434 |
. |
|||||||||||||
EBIT before special items |
–643 |
–769 |
16.4% |
|||||||||||||
of which costs for cross-divisional corporate research |
–355 |
–364 |
2.5% |
|||||||||||||
costs of corporate headquarters |
–255 |
–214 |
–19.2% |
|||||||||||||
other businesses |
180 |
143 |
25.9% |
|||||||||||||
foreign currency results, hedging and other measurement effects |
–62 |
–58 |
–6.9% |
|||||||||||||
miscellaneous income and expenses |
–151 |
–276 |
45.3% |
|||||||||||||
Assetsc |
23,121 |
24,131 |
–4.2% |
|||||||||||||
Investments including acquisitionsd |
183 |
156 |
17.0% |
|||||||||||||
Research and development expenses |
378 |
385 |
–1.8% |
|||||||||||||
|
||||||||||||||||